Celavie’s mission is to improve lives and restore hope by advancing innovations in incurable CNS diseases with regenerative stem cell-based therapies. ​Celavie’s cutting-edge research produces large banks of undifferentiated cells that are grown in a specialized medium allowing uniform reproducible qualities and genetic stability.
Our first FDA IND targets are Parkinson’s Disease and Cerebellar Ataxia.
Our vision is to advance leading-edge science for the benefit of people with loss of basic function or facing mortality.

Contact Celavie Biosciences, Inc.
Visit Website